Calcium effects on epidermal growth factor receptor-mediated endocytosis in normal and SV40-transformed human fibroblasts
- PMID: 6302104
- DOI: 10.1002/jcp.1041150209
Calcium effects on epidermal growth factor receptor-mediated endocytosis in normal and SV40-transformed human fibroblasts
Abstract
Lowering of extracellular Ca2+ levels will reversibly arrest the growth of human fibroblasts (WI38). Simian virus40(SV40)-transformed WI38 cells do not exhibit this Ca2+-dependent arrest. One possibility for this difference in Ca2+ requirement is that extracellular or surface membrane-bound Ca2+ may be required for growth factor receptor-mediated endocytosis and this Ca2+ requirement may differ in normal versus transformed cells. In this study we have evaluated the role of Ca2+ in the binding, internalization, and degradation of epidermal growth factor (EGF) in the WI38 and SV40WI38 cell. The binding of [125I]EGF to the cell surface is not significantly altered by lowering of Ca2+ to 10(5)-M levels in either the normal or transformed cell. At this Ca2+ level, growth of the normal cell is inhibited. The subsequent internalization of EGF is reduced nearly threefold in the normal cell but not in the transformed cell following Ca2+ deprivation. Degradation of the EGF-receptor complex is also sensitive to Ca2+. A twofold reduction in the rate of release of acid-soluble 125I occurs in the normal but not the transformed cell under conditions of lowered medium Ca2+. In contrast, 2-chloro-10-3-aminopropyl phenothiazine (CP), an inhibitor of the Ca2+-dependent regulator protein calmodulin, causes an inhibition of [125I]EGF internalization and degradation in both the normal and transformed WI38 cell, and a marked inhibition of [125I]EGF binding to the cell surface receptor of the transformed cell but not the normal cell.
Similar articles
-
Loss of alpha 2-macroglobulin and epidermal growth factor surface binding induced by phenothiazines and naphthalene sulfonamides.J Cell Physiol. 1984 Feb;118(2):193-202. doi: 10.1002/jcp.1041180212. J Cell Physiol. 1984. PMID: 6319437
-
Down regulation and recovery of the epidermal growth factor receptor in serum supplemented versus defined medium.J Cell Physiol. 1982 Oct;113(1):125-8. doi: 10.1002/jcp.1041130120. J Cell Physiol. 1982. PMID: 6290507
-
Epidermal growth factor stimulates fluid phase endocytosis in human fibroblasts through a signal generated at the cell surface.J Cell Biochem. 1982;19(4):383-94. doi: 10.1002/jcb.240190407. J Cell Biochem. 1982. PMID: 6298257
-
Role of epidermal growth factor in carcinogenesis.Cancer Res. 1986 Mar;46(3):1030-7. Cancer Res. 1986. PMID: 3002608 Review.
-
Role of growth factors and their receptors in the control of normal cell proliferation and cancer.Clin Physiol Biochem. 1987;5(3-4):130-9. Clin Physiol Biochem. 1987. PMID: 3040317 Review.
Cited by
-
Extracellular calcium modulates insulin's action on enzymes controlling cyclic AMP metabolism in intact hepatocytes.Biochem J. 1993 Jul 1;293 ( Pt 1)(Pt 1):249-53. doi: 10.1042/bj2930249. Biochem J. 1993. PMID: 8392336 Free PMC article.
-
The growth of WI-38 cells in a serum-free, growth factor-free, medium with elevated calcium concentrations.In Vitro Cell Dev Biol. 1986 Jun;22(6):355-9. doi: 10.1007/BF02623410. In Vitro Cell Dev Biol. 1986. PMID: 3759791
-
Calmodulin antagonists decrease the binding of epidermal growth factor to transformed, but not to normal, human fibroblasts.Biochem J. 1984 Mar 1;218(2):629-32. doi: 10.1042/bj2180629. Biochem J. 1984. PMID: 6324761 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous